XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Series Seed
Series A
Series B
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020 [1]   13,174,805 16,836,436 22,164,724        
Beginning balance at Dec. 31, 2020   $ 5,494 $ 27,067 $ 75,857        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) [1]   (13,174,805) (16,836,436) (22,164,724)        
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization   $ (5,494) $ (27,067) $ (75,857)        
Ending balance (in shares) at Jun. 30, 2021 [1]   0 0 0        
Ending balance at Jun. 30, 2021   $ 0 $ 0 $ 0        
Beginning balance (in shares) at Dec. 31, 2020 [1]         33,069,513      
Beginning balance at Dec. 31, 2020 $ (29,721)       $ 1 $ 600 $ 3 $ (30,325)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of vested stock options (in shares) [1]         65,003      
Issuance of common stock upon exercise of vested stock options 46         46    
Issuance of common stock upon exercise of warrants (in shares) [1]         62,772      
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) [1]         52,175,965      
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 108,418       $ 7 108,411    
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares) [1]         38,721,137      
Issuance of common stock upon the reverse recapitalization, net of issuance costs 327,280       $ 4 327,276    
Stock-based compensation expense 3,156         3,156    
Other comprehensive loss (13)           (13)  
Net loss (19,122)             (19,122)
Ending balance (in shares) at Jun. 30, 2021 [1]         124,094,390      
Ending balance at Jun. 30, 2021 390,044       $ 12 439,489 (10) (49,447)
Beginning balance (in shares) at Mar. 31, 2021 [1]   13,174,805 16,836,436 22,164,724        
Beginning balance at Mar. 31, 2021   $ 5,494 $ 27,067 $ 75,857        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) [1]   (13,174,805) (16,836,436) (22,164,724)        
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization   $ (5,494) $ (27,067) $ (75,857)        
Ending balance (in shares) at Jun. 30, 2021 [1]   0 0 0        
Ending balance at Jun. 30, 2021   $ 0 $ 0 $ 0        
Beginning balance (in shares) at Mar. 31, 2021 [1]         33,069,513      
Beginning balance at Mar. 31, 2021 (36,795)       $ 1 1,936 2 (38,734)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of vested stock options (in shares) [1]         65,003      
Issuance of common stock upon exercise of vested stock options 46         46    
Issuance of common stock upon exercise of warrants (in shares) [1]         62,772      
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) [1]         52,175,965      
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 108,418       $ 7 108,411    
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares) [1]         38,721,137      
Issuance of common stock upon the reverse recapitalization, net of issuance costs 327,280       $ 4 327,276    
Stock-based compensation expense 1,820         1,820    
Other comprehensive loss (12)           (12)  
Net loss (10,713)             (10,713)
Ending balance (in shares) at Jun. 30, 2021 [1]         124,094,390      
Ending balance at Jun. 30, 2021 $ 390,044       $ 12 439,489 (10) (49,447)
Beginning balance (in shares) at Dec. 31, 2021 [1]   0 0 0        
Beginning balance at Dec. 31, 2021   $ 0 $ 0 $ 0        
Ending balance (in shares) at Jun. 30, 2022 0 0 [1] 0 [1] 0 [1]        
Ending balance at Jun. 30, 2022   $ 0 $ 0 $ 0        
Beginning balance (in shares) at Dec. 31, 2021 [1]         124,303,083      
Beginning balance at Dec. 31, 2021 $ 363,576       $ 12 444,388 (184) (80,640)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of vested stock options (in shares) 211,309       211,309      
Issuance of common stock upon exercise of vested stock options $ 188         188    
Issuance of common stock under employee stock purchase plan (in shares)         48,353      
Issuance of common stock under employee stock purchase plan 153         153    
Stock-based compensation expense 4,677         4,677    
Other comprehensive loss (584)           (584)  
Net loss (30,452)             (30,452)
Ending balance (in shares) at Jun. 30, 2022 [1]         124,562,745      
Ending balance at Jun. 30, 2022 $ 337,558       $ 12 449,406 (768) (111,092)
Beginning balance (in shares) at Mar. 31, 2022   0 0 0        
Beginning balance at Mar. 31, 2022   $ 0 $ 0 $ 0        
Ending balance (in shares) at Jun. 30, 2022 0 0 [1] 0 [1] 0 [1]        
Ending balance at Jun. 30, 2022   $ 0 $ 0 $ 0        
Beginning balance (in shares) at Mar. 31, 2022         124,456,653      
Beginning balance at Mar. 31, 2022 $ 349,709       $ 12 446,654 (554) (96,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of vested stock options (in shares)         57,739      
Issuance of common stock upon exercise of vested stock options 32         32    
Issuance of common stock under employee stock purchase plan (in shares)         48,353      
Issuance of common stock under employee stock purchase plan 153         153    
Stock-based compensation expense 2,567         2,567    
Other comprehensive loss (214)           (214)  
Net loss (14,689)             (14,689)
Ending balance (in shares) at Jun. 30, 2022 [1]         124,562,745      
Ending balance at Jun. 30, 2022 $ 337,558       $ 12 $ 449,406 $ (768) $ (111,092)
[1] (1)    The shares of the Company’s common and redeemable convertible preferred stock, prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 3.6281 established in the Business Combination as described in Note 3.